Sign in

CIK 0001439725

  • Non-accelerated filer
  • Smaller reporting company

BIODESIX INC

Sign in to watch
Ticker
BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203986492
Phone
+1 303-417-0500
Business address
919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Director bought 56,782 shares at $1.15 ($65,066)
  3. 4 Open-market buy Director bought 29,425 shares at $1.11 ($32,529)
  4. 4 Open-market sale CFO, Sec'y & Treasurer sold 3,485 shares at an average $1.57 ($5,468)
  5. 4 Open-market sale Chief Commercial Officer sold 1,697 shares at an average $1.57 ($2,663)
  6. 4 Open-market sale Chief Accounting Officer sold 2,020 shares at an average $1.57 ($3,170)
  7. 4 Open-market sale President & CEO sold 13,782 shares at an average $1.57 ($21,625)
  8. 4 Open-market sale Chief Development Officer sold 1,527 shares at an average $1.57 ($2,396)
  9. 4 Exercise or conversion Director acquired 145,833 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 145,833 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 150,711 shares (option exercise)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Chief Development Officer sold 1,852 shares at $1.80 ($3,332)
  18. 4 Open-market sale President & CEO sold 16,278 shares at $1.80 ($29,286)
  19. 4 Open-market sale Chief Accounting Officer sold 2,016 shares at $1.80 ($3,627)
  20. 4 Open-market sale CFO, Sec'y & Treasurer sold 4,220 shares at $1.80 ($7,592)

Page 10 of 17 · 336 filings